Phoenix from the flames for Lilly cancer drug
August 14, 2013Research and Development, Sales and Marketing NSCLC, lilly, lung cancer, necitumumab
A drug that once looked doomed to fail has shocked analysts by helping late-stage lung cancer patients live longer. Necitumumab …
New president and chief executive for EMMES
August 14, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMMES
Research support firm The EMMES Corporation has announced that its executive VP Dr Anne Lindblad has been promoted to president …
FDA project will examine abuse-resistant formulations
August 13, 2013Manufacturing and Production API, CDC, FDA
The FDA is seeking tenders for a research project to examine how effective tamper-resistant formulations of opioid analgesics really are …
The new NHS: a marriage of inconvenience?
August 13, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CCG, NHS England, andy lee, market access, quarry house
As NHS England tries to squeeze more money out of the healthcare budget to pay for specialist commissioning, Andy Lee …
Rebrand for Just:: comms agency
August 13, 2013Medical Communications Just:: Health
London-based healthcare agency Just:: Health PR has changed its name to Just:: Health Communications. The move is in response to …
Vical melanoma drug dropped
August 13, 2013Research and Development, Sales and Marketing Vical, allovectin, melanoma
Vical has abandoned trials of a late-stage drug for the deadliest form of skin cancer after the treatment failed to …
Bribery ‘routine’ for pharma in China
August 13, 2013Sales and Marketing BBC, China, GSK, Sanofi, bribery, drug reps
Sanaria’s malaria vaccine shows promise
August 9, 2013Research and Development, Sales and Marketing PfSPZ, Vaccine, malaria, sanaria
Researchers in the US have announced promising results from a Phase I clinical trial of biotech firm Sanaria’s new malaria …
AllTrials campaign releases manifesto
August 9, 2013Medical Communications, Research and Development, Sales and Marketing Bad pharma, GSK, Goldacre, NICE, transparency
The UK clinical trial transparency initiative AllTrials has released its first detailed manifesto as it looks to ramp up pressure …
Ranbaxy taps into Malaysian growth with second facility
August 9, 2013Manufacturing and Production ASEAN, Ranbaxy, asian, malaysian
Indian drugmaker Ranbaxy has signed a deal to construct a new $35 million manufacturing facility in Malaysia that will triple …
GSK banks on bioelectronics with new fund
August 9, 2013Medical Communications, Research and Development, Sales and Marketing Bioelectronics, COPD, GSK, asthma, diabetes
GSK has established a $50 million venture capital fund to invest in the emerging field of bioelectronics. Described as one …
BMJ appoints US managing director
August 9, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMJ, Campbell
Medical journal BMJ has hired Glen Campbell from Elsevier to be its US managing director. Campbell joins BMJ on 2 …
GSK seeks licence extensions
August 8, 2013Sales and Marketing Cervarix, EMA, GSK, Votrient
GlaxoSmithKline is seeking to extend the licences of two of its brands, Cervarix and Votrient, in a bid to extend …
Novartis recognised for efforts in cancer
August 8, 2013Medical Communications, Sales and Marketing Bush, CEO, Cancer, Novartis
Novartis is the first company to earn a global CEO Cancer Gold Standard accreditation by the non-profit organisation CEO Roundtable …
Late-stage failure for Afinitor
August 8, 2013Research and Development, Sales and Marketing Afinitor, Cancer, Novartis, liver
Novartis’ oncology programme has received a blow with the news that Afinitor has failed to help patients live longer in …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
